<DOC>
	<DOCNO>NCT00288951</DOCNO>
	<brief_summary>The purpose study determine safety IOP-lowering ability glaucoma therapy patient open-angle glaucoma ocular hypertension</brief_summary>
	<brief_title>Phase III Safety Efficacy Study Evaluate Glaucoma Therapy Open-Angle Glaucoma Ocular Hypertension Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Travoprost</mesh_term>
	<criteria>Adult subject either sex race 18 year old openangle glaucoma ocular hypertension . Patients logMAR visual acuity worse 0.6 either eye clinically relevant ophthalmic/systemic condition exclude . See Inclusion Criteria</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>